These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22050597)

  • 41. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM; Pearse RN
    Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
    Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
    Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple squamous cell carcinomas in the setting of psoriasis treated with etanercept: a report of four cases and review of the literature.
    Brewer JD; Hoverson Schott AR; Roenigk RK
    Int J Dermatol; 2011 Dec; 50(12):1555-9. PubMed ID: 22098006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept.
    Di Nuzzo S; Zanni M; De Panfilis G
    J Drugs Dermatol; 2007 Oct; 6(10):1046-7. PubMed ID: 17966184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etanercept treatment for children and adolescents with plaque psoriasis.
    Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A;
    N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model.
    Raychaudhuri SP; Kundu-Raychaudhuri S; Tamura K; Masunaga T; Kubo K; Hanaoka K; Jiang WY; Herzenberg LA; Herzenberg LA
    J Invest Dermatol; 2008 Aug; 128(8):1969-76. PubMed ID: 18337836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe combined immunodeficiency mouse-psoriatic human skin xenograft model: a modern tool connecting bench to bedside.
    Kundu-Raychaudhuri S; Datta-Mitra A; Abria CJ; Peters J; Raychaudhuri SP
    Indian J Dermatol Venereol Leprol; 2014; 80(3):204-13. PubMed ID: 24823397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.
    Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G
    Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Debio 0932, a new oral Hsp90 inhibitor, alleviates psoriasis in a xenograft transplantation model.
    Stenderup K; Rosada C; Gavillet B; Vuagniaux G; Dam TN
    Acta Derm Venereol; 2014 Nov; 94(6):672-6. PubMed ID: 24604074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
    Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
    J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model.
    Gilhar A; Bergman R; Assay B; Ullmann Y; Etzioni A
    J Invest Dermatol; 2011 Jan; 131(1):118-24. PubMed ID: 20739949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.
    Bak RO; Stenderup K; Rosada C; Petersen LB; Moldt B; Dagnæs-Hansen F; Jakobsen M; Kamp S; Jensen TG; Dam TN; Mikkelsen JG
    BMC Dermatol; 2011 Feb; 11():5. PubMed ID: 21352568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model.
    Nickoloff BJ
    Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of p38 kinase suppresses the development of psoriasis-like lesions in a human skin transplant model of psoriasis.
    Mihara K; Elliott GR; Boots AM; Nelissen RL
    Br J Dermatol; 2012 Aug; 167(2):455-7. PubMed ID: 22413906
    [No Abstract]   [Full Text] [Related]  

  • 57. Antipsoriatic activity of extracts and fractions obtained from Memecylon malabaricum leaves.
    Dhanabal SP; Muruganantham N; Basavaraj KH; Wadhwani A; Shamasundar NM
    J Pharm Pharmacol; 2012 Oct; 64(10):1501-9. PubMed ID: 22943181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A/B and EZH2 in lesional psoriatic skins.
    Liu Y; Luo W; Chen S
    Mol Biol Rep; 2011 Aug; 38(6):4219-24. PubMed ID: 21116854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation.
    Raychaudhuri SP; Dutt S; Raychaudhuri SK; Sanyal M; Farber EM
    Br J Dermatol; 2001 May; 144(5):931-9. PubMed ID: 11359377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model.
    Jakobsen M; Stenderup K; Rosada C; Moldt B; Kamp S; Dam TN; Jensen TG; Mikkelsen JG
    Mol Ther; 2009 Oct; 17(10):1743-53. PubMed ID: 19568223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.